Skip to content
OpenCapital
Get started

Rallybio Corporation RLYB Q4 2024 Annual earnings

Reported March 13, 2025 · Before market open

Revenue$38.0KMiss by $111.5K
EPS-$0.25Beat by $0.02
Revenue estimate$149.5K
EPS estimate-$0.27

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$216.5K
EPS estimate-$1.28

Versus estimates

Revenue

Q1 2026$212.0KIn lineQ4 2025$222.0KBeat by $122.0KQ3 2025$212.0KBeat by $145.3KQ2 2025$212.0KBeat by $145.3KQ1 2025$212.0K
Q4 2024$38.0KMiss by $111.5K

Diluted EPS

Q1 2026-$1.46Miss by $0.26Q4 2025-$1.28Miss by $0.04Q3 2025-$0.14Beat by $0.11Q2 2025-$0.22Miss by $0.02Q1 2025-$0.21In line
Q4 2024-$0.25Beat by $0.02

Ask the moment Rallybio Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rallybio Corporation report Q4 2024 earnings?
Rallybio Corporation (RLYB) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Rallybio Corporation's Q4 2024 revenue and EPS?
Rallybio Corporation reported revenue of $38.0K and eps of $-0.25 for Q4 2024.
Did Rallybio Corporation beat estimates in Q4 2024?
Revenue missed the consensus estimate of $149.5K by $111.5K. EPS beat the consensus estimate of $-0.27 by $0.02.
Where can I find Rallybio Corporation's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001739410-25-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.